Author's posts
Signify Health Stock Surges As Amazon Reportedly Joins Potential Bidding War With CVS, UnitedHealth
Share of Signify jumped 40% on reports that a bidding war could value the firm at more than $8 billion.
Cathie Wood’s Ark Invest Buys Moderna Stock After $100 Billion Crash—And Sells Rival Vaccine Maker Pfizer
Shares of Moderna have tumbled 40% this year, Ark’s Genomic Revolution ETF nearly 50%.
Billionaire Moderna CEO Stéphane Bancel Pledges Stock Options Worth $355 Million To Undisclosed Charitable Causes
Despite a steep Moderna stock crash this year, the longtime biotech executive has amassed a $4.6 billion fortune.
Moderna Stock Plunges Despite ‘Vaccine Day’ Touting 31 New Shots And $21 Billion In Sales—Here’s Why
One analyst blasted Moderna’s flu vaccine results as a “nonstarter” clinically, while others said investors are still too focused on Covid.
Biden Signs $1.5 Trillion Spending Bill With $14 Billion For Ukraine Aid—Here’s What’s In It
In addition to funding day-to-day government operations, the bill includes measures targeting student aid, violence against women and e-cigarette regulation.
Moderna Stock Crash Worsens Even After Morgan Stanley Says Flu Vaccine Results Could Boost Shares
Moderna stock fell 6% despite the bullish projection, pushing shares down nearly 72% below their August all-time high.
Moderna Stock Crash: Losses Top $140 Billion As Insiders Sell Millions Of Dollars In Shares
One of last year’s best-performing stocks, Moderna has plummeted more than 70% from its all-time high six months ago.
Pfizer Triggers $28 Billion Stock Plunge After Warning Covid Vaccine Sales May Disappoint This Year
Despite nabbing $12.5 billion in Covid vaccine sales last year, Pfizer stock plunged as much as 6% Tuesday.
Moderna Stock Crash Intensifies: Losses Top $130 Billion After Scientists Find Covid Boosters Aren’t Halting Omicron Infections
Moderna was last year’s third-best-performing stock in the S&P—it’s now this year’s worst.
Covid Case Counts Should No Longer Be ‘Major’ Pandemic Metric Amid ‘Mild’ Omicron Infections, Experts Argue
“That’s the vaccine working,” U.S. public health expert Ashish Jha said Sunday of the growing number of mild, cold-like Covid infections among vaccinated Americans, arguing that policymakers should pay more attention to hospitalization numbers than the…
